 |
|
COMMENTS AND OPINIONS
Alopecia Impairs the Quality of Life of Patients With Lupus Erythematosus
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
The assessment of quality of life in dermatology patients has gained increased attention in the past decade.1 This trend can be observed when we evaluate the number of articles published and indexed by MEDLINE using the specific MESH terms quality of life, quality of life and skin diseases, and Dermatology Life Quality Index (DLQI)2 in different year periods (Table 1). The number of articles published increased considerably in the past 4 years. It denotes the recognition by the dermatology scientific community of an increasing interest to assess more globally the impact of skin diseases in the health of patients.
Table appears in full text version.
|
|
|
|
Table 1. Number of Articles Published and Indexed by MEDLINE up to April 25, 2005, According to Defined MESH Terms*
|
|
|
In a recent study, the Brazilian-Portuguese version of the DLQI was shown to be a reliable (interobserver reliability coefficient, r = 0.9613; P<.001) and valid quality of life . . . [Full Text of this Article]
AUTHOR INFORMATION
Luci Biaggi Ferraz, MD, MSc;
Fernando A. de Almeida, MD, PhD;
Monica R. A. Vasconcellos, MD, MSc;
Marcos Bosi Ferraz, MD, PhD
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
High dose cyclophosphamide performs better than monthly dose cyclophosphamide in quality of life measures
Dussan et al.
Lupus 2008;17:1079-1085.
ABSTRACT
|
